This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

17 Dec 2010

Study Shows Nanosphere Verisens Ctni Ultra-Sensitive Troponin I Assay Predicts Heart Failure Deterioration

A clinical study released online demonstrates the value of using Nanosphere’s Verisens cTnI assay (RUO) to detect very low levels of troponin I in hospitalized patients with heart failure.

Related News